Con and Temporary: The Tipline for 7 February 2018
In addition to convincing the government that its $69 billion acquisition of Aetna does not run afoul of the antitrust laws, CVS Health must now defend a tying claim in federal court – or settle the lawsuit, pressure for which which could have been the plaintiff’s strategy for filing the complaint now.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10